• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习加速从天然产物中筛选破骨细胞分化抑制剂。

Machine Learning Accelerates Screening of Osteoclast Differentiation Inhibitors from Natural Products.

机构信息

Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan.

International Research Center for Agricultural and Environmental Biology (IRCAEB), 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan.

出版信息

J Nat Prod. 2024 Oct 25;87(10):2393-2397. doi: 10.1021/acs.jnatprod.4c00640. Epub 2024 Oct 4.

DOI:10.1021/acs.jnatprod.4c00640
PMID:39364554
Abstract

Natural products that inhibit osteoclast differentiation are promising therapeutic and preventive agents for osteoporosis. Conventionally, identifying osteoclast differentiation involves visual inspection of the microscope images of stained osteoclasts. In this study, a supervised machine learning model was developed to classify bright-field microscope images of osteoclasts without staining. The model was used to screen a compound library, and osteoclast differentiation inhibitors were identified, demonstrating the validity of our method. Next, an in-house library of fungal extracts was screened, and pinolidoxin was revealed as an inhibitor of osteoclast differentiation. Our machine learning method enabled accurate, objective, and high-throughput evaluation of osteoclast differentiation and efficient screening of the inhibitors from natural product extracts. This study represents the first machine learning classification developed to evaluate the inhibitory activity of natural products in osteoclast differentiation.

摘要

天然产物抑制破骨细胞分化是治疗和预防骨质疏松症的有前途的药物。传统上,鉴定破骨细胞分化需要通过观察染色破骨细胞的显微镜图像来进行。在这项研究中,开发了一种监督机器学习模型,用于对未染色的破骨细胞明场显微镜图像进行分类。该模型用于筛选化合物文库,并鉴定出破骨细胞分化抑制剂,证明了我们方法的有效性。接下来,对一个真菌提取物的内部文库进行了筛选,发现表松脂素是破骨细胞分化的抑制剂。我们的机器学习方法能够准确、客观、高通量地评估破骨细胞分化,并从天然产物提取物中有效筛选抑制剂。这项研究代表了第一个用于评估天然产物在破骨细胞分化中的抑制活性的机器学习分类方法。

相似文献

1
Machine Learning Accelerates Screening of Osteoclast Differentiation Inhibitors from Natural Products.机器学习加速从天然产物中筛选破骨细胞分化抑制剂。
J Nat Prod. 2024 Oct 25;87(10):2393-2397. doi: 10.1021/acs.jnatprod.4c00640. Epub 2024 Oct 4.
2
The Natural Product 6-Gingerol Inhibits Inflammation-Associated Osteoclast Differentiation via Reduction of Prostaglandin E₂ Levels.天然产物 6-姜酚通过降低前列腺素 E₂水平抑制炎症相关破骨细胞分化。
Int J Mol Sci. 2018 Jul 16;19(7):2068. doi: 10.3390/ijms19072068.
3
Suppression of adjuvant-induced arthritic bone destruction by cyclooxygenase-2 selective agents with and without inhibitory potency against carbonic anhydrase II.具有或不具有对碳酸酐酶II抑制活性的环氧化酶-2选择性药物对佐剂诱导的关节炎性骨破坏的抑制作用
J Bone Miner Res. 2006 Feb;21(2):219-27. doi: 10.1359/JBMR.051025. Epub 2005 Nov 7.
4
RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.核因子κB受体活化因子配体(RANKL)通过细胞周期蛋白依赖性激酶抑制剂p27KIP1和p21CIP1来协调破骨细胞的细胞周期停滞和分化。
J Bone Miner Res. 2004 Aug;19(8):1339-48. doi: 10.1359/JBMR.040321. Epub 2004 Mar 29.
5
Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis.木瓜抑制破骨细胞分化,防止去卵巢诱导的骨质疏松症,其作用机制与抑制 NFATc1 表达有关。
BMC Complement Med Ther. 2020 Feb 5;20(1):35. doi: 10.1186/s12906-020-2841-9.
6
Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption.鸡血藤水提物抑制破骨细胞分化和骨吸收。
BMC Complement Altern Med. 2013 May 21;13:112. doi: 10.1186/1472-6882-13-112.
7
Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.甘草酸通过调节 NF-κB、ERK 和 JNK 信号通路抑制破骨细胞分化和绝经后骨质疏松症。
Eur J Pharmacol. 2019 Sep 15;859:172550. doi: 10.1016/j.ejphar.2019.172550. Epub 2019 Jul 16.
8
Impact of the SIK3 pathway inhibition on osteoclast differentiation via oxidative phosphorylation.SIK3 通路抑制通过氧化磷酸化对破骨细胞分化的影响。
J Bone Miner Res. 2024 Sep 2;39(9):1340-1355. doi: 10.1093/jbmr/zjae105.
9
Synthesis and biological evaluation of rhein amides as inhibitors of osteoclast differentiation and bone resorption.大黄酰胺类化合物的合成及对破骨细胞分化和骨吸收的抑制作用的生物学评价。
Eur J Med Chem. 2016 Nov 10;123:769-776. doi: 10.1016/j.ejmech.2016.08.004. Epub 2016 Aug 6.
10
A review on osteoclast diseases and osteoclastogenesis inhibitors recently developed from natural resources.从天然资源中开发的破骨细胞疾病和破骨细胞生成抑制剂的研究进展综述。
Fitoterapia. 2020 Apr;142:104482. doi: 10.1016/j.fitote.2020.104482. Epub 2020 Jan 16.

引用本文的文献

1
Causal relationships between immune cell subtypes and risk of Pneumocystis pneumonia and lung cancer: a Mendelian randomization study.免疫细胞亚型与肺孢子菌肺炎和肺癌风险之间的因果关系:一项孟德尔随机化研究
Discov Oncol. 2025 Jun 6;16(1):1014. doi: 10.1007/s12672-025-02875-8.
2
Stereoselective Total Synthesis of Natural Decanolides Bellidisin C and Pinolidoxin.天然癸内酯贝利地辛C和松果毒素的立体选择性全合成
Molecules. 2024 Nov 21;29(23):5500. doi: 10.3390/molecules29235500.